| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8ef0dc4f0469412bce2a9428cdfa227 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-15 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0784
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate |
2012-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc22dc5c7b88c2c4eeea111ced04b703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2265a2b61af92b82584d0d7a2a671b7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_260a9ce1971ae4bbea5a1475e0a375de |
| publicationDate |
2012-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2012191952-A |
| titleOfInvention |
Dendritic cells, medicaments containing the dendritic cells, therapeutic methods using the dendritic cells, and γδ T cell culture methods |
| abstract |
The present invention relates to a dendritic cell for efficiently activating and / or proliferating γδT cells in vivo and / or in vitro, a medicament containing the same, a method of treatment using the dendritic cell, and the method A method for culturing γδT cells using dendritic cells is provided. The immature dendritic cells derived from peripheral blood mononuclear cells are pulsed with a bisphosphonate bone metabolism-improving drug to have the ability to activate γδT cells, and then cultured with a cell group containing γδT cells. To activate and / or proliferate γδ T cells. This makes it possible to easily proliferate γδT cells without imposing a burden on the patient, leading to the practical application of immune cell therapy using γδT cells. [Selection figure] None |
| priorityDate |
2004-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |